» Articles » PMID: 33991530

The Kidney Hepcidin/ferroportin Axis Controls Iron Reabsorption and Determines the Magnitude of Kidney and Systemic Iron Overload

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 2021 May 15
PMID 33991530
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The hepcidin/ferroportin axis controls systemic iron homeostasis by regulating iron acquisition from the duodenum and reticuloendothelial system, respective sites of iron absorption and recycling. Ferroportin is also abundant in the kidney, where it has been implicated in tubular iron reabsorption. However, it remains unknown whether endogenous hepcidin regulates ferroportin-mediated iron reabsorption under physiological conditions, and whether such regulation is important for kidney and/or systemic iron homeostasis. To address these questions, we generated a novel mouse model with an inducible kidney-tubule specific knock-in of fpnC326Y, which encodes a hepcidin-resistant ferroportin termed FPNC326Y. Under conditions of normal iron availability, female mice harboring this allele had consistently decreased kidney iron but only transiently increased systemic iron indices. Under conditions of excess iron availability, male and female mice harboring this allele had milder kidney iron overload, but greater systemic iron overload relative to controls. Additionally, despite comparable systemic iron overload, kidney iron overload occurred in wild type mice fed an iron-loaded diet but not in hemochromatosis mice harboring a ubiquitous knock-in of fpnC326Y. Thus, our study demonstrates that endogenous hepcidin controls ferroportin-mediated tubular iron reabsorption under physiological conditions. It also shows that such control is important for both kidney and systemic iron homeostasis in the context of iron overload.

Citing Articles

Research progress of traditional Chinese medicines in regulating acute kidney injury-related ferroptosis: a literature review.

Peng T, Li M Int Urol Nephrol. 2024; .

PMID: 39680293 DOI: 10.1007/s11255-024-04302-3.


Advances of Iron and Ferroptosis in Diabetic Kidney Disease.

Chu J, Wang K, Lu L, Zhao H, Hu J, Xiao W Kidney Int Rep. 2024; 9(7):1972-1985.

PMID: 39081773 PMC: 11284386. DOI: 10.1016/j.ekir.2024.04.012.


Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction.

Matsuoka T, Abe M, Kobayashi H Int J Mol Sci. 2024; 25(7).

PMID: 38612557 PMC: 11012052. DOI: 10.3390/ijms25073745.


Iron deficiency and supplementation in heart failure.

Lakhal-Littleton S, Cleland J Nat Rev Cardiol. 2024; 21(7):463-486.

PMID: 38326440 DOI: 10.1038/s41569-024-00988-1.


Renal-specific loss of ferroportin disrupts iron homeostasis and attenuates recovery from acute kidney injury.

Soofi A, Li V, Beamish J, Abdrabh S, Hamad M, Das N Am J Physiol Renal Physiol. 2023; 326(2):F178-F188.

PMID: 37994409 PMC: 11198972. DOI: 10.1152/ajprenal.00184.2023.


References
1.
Moulouel B, Houamel D, Delaby C, Tchernitchko D, Vaulont S, Letteron P . Hepcidin regulates intrarenal iron handling at the distal nephron. Kidney Int. 2013; 84(4):756-66. DOI: 10.1038/ki.2013.142. View

2.
Veiras L, Girardi A, Curry J, Pei L, Ralph D, Tran A . Sexual Dimorphic Pattern of Renal Transporters and Electrolyte Homeostasis. J Am Soc Nephrol. 2017; 28(12):3504-3517. PMC: 5698077. DOI: 10.1681/ASN.2017030295. View

3.
Aydemir F, Jenkitkasemwong S, Gulec S, Knutson M . Iron loading increases ferroportin heterogeneous nuclear RNA and mRNA levels in murine J774 macrophages. J Nutr. 2009; 139(3):434-8. PMC: 2646225. DOI: 10.3945/jn.108.094052. View

4.
Christensen E, Birn H, Storm T, Weyer K, Nielsen R . Endocytic receptors in the renal proximal tubule. Physiology (Bethesda). 2012; 27(4):223-36. DOI: 10.1152/physiol.00022.2012. View

5.
Veuthey T, DAnna M, Roque M . Role of the kidney in iron homeostasis: renal expression of Prohepcidin, Ferroportin, and DMT1 in anemic mice. Am J Physiol Renal Physiol. 2008; 295(4):F1213-21. DOI: 10.1152/ajprenal.90216.2008. View